Abstract
A just-signed supply agreement is setting a new standard for low costs and high volume in the synthetic biology market. Twist Bioscience has agreed to supply at least 100 million base pairs of synthetic DNA over a one-year period to Ginkgo Bioworks, which will use the DNA to engineer prototype organisms for customers. Both companies are hot prospects in synthetic biology. Seven-year-old Ginkgo raised about $54 million this year and has at least 20 organism design contracts under way. Twist amassed $82 million over two years to develop its silicon wafer-based process for DNA synthesis. The synthetic biology market will grow more than 30% per year to reach nearly $12 billion by 2018, according to BCC Research. Yet most of those sales will be of end products. Demand for DNA synthesis is also rising, but prices are falling as advances are made. In fact, Ginkgo’s deal with Twist stipulates that ...
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
